Atlas Trials

Incidence of Hepatitis B Virus (HBV) Reactivation in HBsAg Negative/HBcAb Positive Lymphoma Patients Treated With RCHOP

Clinical trial NCT01210287 · UNKNOWN

Trial details

NCT number
NCT01210287
Sponsor
Fudan University
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Lymphoma
Start date
2010-10-01
Primary completion
2014-08-01
Enrollment
110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.